CIK 0000898437 · Accelerated filer
Anika Therapeutics, Inc.
Sign in to watch- Ticker
- ANIK
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043145961
- Phone
- (781) 457-9000
- Business address
- 32 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ANIKA THERAPEUTICS INC, ANIKA RESEARCH INC
- 4 Option exercise President, CEO, Director acquired 24,576 shares (option exercise)
- DEF 14A Proxy Proxy Statement
- DEFA14A Proxy Proxy Materials
- 4 Open-market buy EVP, General Counsel, Corp Sec bought 1,500 shares at $26.65 ($39,978)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 2,000 shares at $24.66 ($49,318)
- 4 Open-market buy President, CEO, Director bought 8,100 shares at an average $25.57 ($207,143)
- 4 Open-market buy EVP, CFO, Treasurer bought 4,000 shares at $24.62 ($98,476)
- 4 Option exercise EVP, CFO, Treasurer acquired 4,438 shares (option exercise)
- 4 Shares withheld for taxes EVP, Human Resources gave up 748 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Counsel, Corp Sec gave up 1,081 shares (to pay taxes)
- 4 Option exercise President, CEO, Director acquired 14,420 shares (option exercise)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes EVP, General Counsel, Corp Sec gave up 734 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Human Resources gave up 1,713 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 12 of 55 · 1,098 filings